xml version="1.0" encoding="UTF-8"?


C\_2018272EN.01001801.xml


| | | | |
| --- | --- | --- | --- |
| 3.8.2018 | EN | Official Journal of the European Union | C 272/18 |

---

Prior notification of a concentration

(Case M.9051 — Sheares Healthcare/TPG Growth/AHH)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 272/08)

1.

On 27 July 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018272EN.01001801-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Sheares Healthcare Group Pte. Ltd. (‘Sheares Healthcare’, Singapore), belonging to Temasek (Singapore), |

| | |
| --- | --- |
| — | TPG Growth III SF Pte. Ltd. (‘TPG Growth’, Singapore), belonging to TPG (USA), |

| | |
| --- | --- |
| — | Asia Healthcare Holdings Pte. Ltd. (‘AHH’, Singapore), controlled by TPG Growth. |

Sheares Healthcare and TPG Growth acquire within the meaning of Articles 3(1)(b) and 3(4)of the Merger Regulation joint control of the whole of AHH.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Sheares Healthcare: provision of healthcare delivery services in Asia. Temasek is a global investment company,

—   for TPG Growth: part of TPG, a private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings,

—   for AHH: holds controlling interests in (i) Rhea healthcare Pte. Ltd., which operates a network of mother and child care service centres in India; and (ii) Cancer Treatment Services International, which operates a network of cancer-focused single-specialty facilities in India.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018272EN.01001801-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9051 — Sheares Healthcare/TPG Growth/AHH

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018272EN.01001801-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018272EN.01001801-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---